Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
Number of events with antidiabetic drugs. The figure shows the effect of antidiabetic drugs (rosiglitazone, metformin, and glyburide) on various cardiovascular adverse events; ; for the comparison between metformin and glyburide treatment groups and the rosiglitazone group. The figure is developed from the data of adverse events shown in the Diabetes Outcome Progression Trial (ADOPT) trial .
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.